Multiple Sclerosis

15 минут назад - перевести

McDonald 2024 Habek M, Adamec I, Gabelić T, Barun B, Krbot Skorić M. Diagnostic performance of the 2010, 2017, and 2024 McDonald criteria: clinical implications in multiple sclerosis. J Neurol. 2025 Sep 20;272(9):637. Objective: To compare the sensitivity (capacity to identify true positives), specificity (capacity to detect true negatives), predictive value, and accuracy of the 2010, 2017, and […]
https://multiple-sclerosis-res....earch.org/2025/09/mc

Discover the world at Altruu, The Discovery Engine

15 минут назад - перевести

McDonald 2024 Habek M, Adamec I, Gabelić T, Barun B, Krbot Skorić M. Diagnostic performance of the 2010, 2017, and 2024 McDonald criteria: clinical implications in multiple sclerosis. J Neurol. 2025 Sep 20;272(9):637. Objective: To compare the sensitivity (capacity to identify true positives), specificity (capacity to detect true negatives), predictive value, and accuracy of the 2010, 2017, and […]
https://multiple-sclerosis-res....earch.org/2025/09/mc

Discover the world at Altruu, The Discovery Engine

1 день назад - перевести

Progressive Multifocal Leucoencephalopathy (PML) Progressive Multifocal Leukoencephalopathy (PML) is a rare but serious brain infection (with high mortality and disability) caused by the reactivation of the JC virus (John Cunningham virus). It’s a concern for some disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS), particularly those that result in dropping your lymphocyte count significantly (T and B cells). […]
https://multiple-sclerosis-res....earch.org/2025/09/pr

Discover the world at Altruu, The Discovery Engine

1 день назад - перевести

Progressive Multifocal Leucoencephalopathy (PML) Progressive Multifocal Leukoencephalopathy (PML) is a rare but serious brain infection (with high mortality and disability) caused by the reactivation of the JC virus (John Cunningham virus). It’s a concern for some disease-modifying therapies (DMTs) used to treat multiple sclerosis (MS), particularly those that result in dropping your lymphocyte count significantly (T and B cells). […]
https://multiple-sclerosis-res....earch.org/2025/09/pr

Discover the world at Altruu, The Discovery Engine

2 дней назад - перевести

Told you so.. Salazar-Camelo A, Vega L, Fadlallah Y, Bou Rjeily N, Balshi A, Morris B, Ghajarzadeh M, Mowry EM, Waubant E, Nourbakhsh B. Finite-course ocrelizumab in relapsing multiple sclerosis: Results of two prospective open-label trials with matched controls. Mult Scler. 2025 Sep 19:13524585251375350. doi: 10.1177/13524585251375350. Epub ahead of print. PMID: 40970353. Background: Whether continuous anti-CD20 therapy is required […]
https://multiple-sclerosis-res....earch.org/2025/09/to

Discover the world at Altruu, The Discovery Engine